Credit Suisse Group assumed coverage on shares of Humana Inc. (NYSE:HUM) in a report published on Thursday morning. The brokerage issued a neutral rating and a $256.00 price target on the insurance provider’s stock.

A number of other brokerages also recently weighed in on HUM. UBS AG reissued a neutral rating and issued a $250.00 price objective (up from $237.00) on shares of Humana in a research note on Wednesday, August 9th. Zacks Investment Research cut Humana from a hold rating to a sell rating in a research report on Thursday, July 27th. Cowen and Company restated a buy rating and set a $230.00 price objective on shares of Humana in a research report on Friday, July 14th. BidaskClub raised Humana from a sell rating to a hold rating in a research note on Thursday, August 10th. Finally, Cantor Fitzgerald reaffirmed a neutral rating and issued a $223.00 price target (up previously from $200.00) on shares of Humana in a research note on Thursday, August 3rd. Thirteen analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The company currently has an average rating of Hold and a consensus price target of $253.71.

Humana (NYSE HUM) traded up $0.34 during trading hours on Thursday, reaching $256.69. The company had a trading volume of 688,568 shares, compared to its average volume of 986,057. The firm has a market capitalization of $37,096.07, a price-to-earnings ratio of 22.30, a P/E/G ratio of 1.66 and a beta of 0.91. Humana has a 1 year low of $165.52 and a 1 year high of $264.56. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.39.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The business had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same quarter last year, the company posted $2.30 EPS. equities analysts anticipate that Humana will post 11.57 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Credit Suisse Group Begins Coverage on Humana Inc. (HUM)” was published by Watch List News and is the property of of Watch List News. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://www.watchlistnews.com/credit-suisse-group-begins-coverage-on-humana-inc-hum/1681272.html.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.62%. Humana’s dividend payout ratio (DPR) is currently 13.06%.

In other Humana news, insider Elizabeth D. Bierbower sold 9,786 shares of the firm’s stock in a transaction on Friday, September 1st. The stock was sold at an average price of $259.00, for a total transaction of $2,534,574.00. Following the transaction, the insider now owns 18,042 shares in the company, valued at approximately $4,672,878. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP M Todoroff Christopher sold 22,935 shares of the firm’s stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $252.52, for a total value of $5,791,546.20. Following the transaction, the vice president now owns 24,001 shares in the company, valued at approximately $6,060,732.52. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 55,595 shares of company stock worth $14,133,706. Corporate insiders own 0.80% of the company’s stock.

A number of institutional investors have recently bought and sold shares of HUM. WFG Advisors LP increased its stake in Humana by 4.5% during the 2nd quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after acquiring an additional 20 shares during the period. Acrospire Investment Management LLC bought a new position in Humana during the 2nd quarter worth $120,000. Independent Portfolio Consultants Inc. increased its stake in Humana by 22.1% during the 2nd quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after acquiring an additional 94 shares during the period. Northwestern Mutual Wealth Management Co. increased its stake in Humana by 139.5% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock worth $134,000 after acquiring an additional 325 shares during the period. Finally, Fiduciary Trust Co. bought a new position in Humana during the 2nd quarter worth $135,000. Hedge funds and other institutional investors own 95.79% of the company’s stock.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Analyst Recommendations for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.